338 related articles for article (PubMed ID: 16051963)
1. Abnormal cytology predicts poor prognosis in cancer patients with pericardial effusion.
Gornik HL; Gerhard-Herman M; Beckman JA
J Clin Oncol; 2005 Aug; 23(22):5211-6. PubMed ID: 16051963
[TBL] [Abstract][Full Text] [Related]
2. Surgical management of symptomatic pericardial effusion in patients with solid malignancies.
Gross JL; Younes RN; Deheinzelin D; Diniz AL; Silva RA; Haddad FJ
Ann Surg Oncol; 2006 Dec; 13(12):1732-8. PubMed ID: 17028771
[TBL] [Abstract][Full Text] [Related]
3. Severe pericardial effusion in patients with concurrent malignancy: a retrospective analysis of prognostic factors influencing survival.
Dequanter D; Lothaire P; Berghmans T; Sculier JP
Ann Surg Oncol; 2008 Nov; 15(11):3268-71. PubMed ID: 18648881
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness and prognosis of initial pericardiocentesis in the primary management of malignant pericardial effusion.
Apodaca-Cruz A; Villarreal-Garza C; Torres-Avila B; Torres J; Meneses A; Flores-Estrada D; Lara-Medina F; Arrieta O
Interact Cardiovasc Thorac Surg; 2010 Aug; 11(2):154-61. PubMed ID: 20504889
[TBL] [Abstract][Full Text] [Related]
5. VATS pericardiotomy for patients with known malignancy and pericardial effusion: survival and prognosis of positive cytology and metastatic involvement of the pericardium: a case control study.
Neragi-Miandoab S; Linden PA; Ducko CT; Bueno R; Richards WG; Sugarbaker DJ; Jaklitsch MT
Int J Surg; 2008 Apr; 6(2):110-4. PubMed ID: 18329349
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of primary and secondary treatment of pericardial effusion in patients with malignancy.
Tsang TS; Seward JB; Barnes ME; Bailey KR; Sinak LJ; Urban LH; Hayes SN
Mayo Clin Proc; 2000 Mar; 75(3):248-53. PubMed ID: 10725950
[TBL] [Abstract][Full Text] [Related]
7. Long-term follow-up of idiopathic chronic pericardial effusion.
Sagristà-Sauleda J; Angel J; Permanyer-Miralda G; Soler-Soler J
N Engl J Med; 1999 Dec; 341(27):2054-9. PubMed ID: 10615077
[TBL] [Abstract][Full Text] [Related]
8. Pericardial effusion after cardiac surgery: risk factors, patient profiles, and contemporary management.
Ashikhmina EA; Schaff HV; Sinak LJ; Li Z; Dearani JA; Suri RM; Park SJ; Orszulak TA; Sundt TM
Ann Thorac Surg; 2010 Jan; 89(1):112-8. PubMed ID: 20103217
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis of malignant pericarditis: a single centre experience.
Pawlak Cieślik A; Szturmowicz M; Fijałkowska A; Gątarek J; Gralec R; Błasińska-Przerwa K; Szczepulska-Wójcik E; Skoczylas A; Bilska A; Tomkowski W
Kardiol Pol; 2012; 70(11):1147-53. PubMed ID: 23180523
[TBL] [Abstract][Full Text] [Related]
10. Pericardiocentesis and intrapericardial sclerosis: effective therapy for malignant pericardial effusions.
Girardi LN; Ginsberg RJ; Burt ME
Ann Thorac Surg; 1997 Nov; 64(5):1422-7; discussion 1427-8. PubMed ID: 9386714
[TBL] [Abstract][Full Text] [Related]
11. [Cardiac tamponade as clinical manifestation of neoplastic process: presentation of 11 cases and review of the literature].
García Vázquez E
An Med Interna; 2000 Jan; 17(1):25-8. PubMed ID: 10730401
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic value of the biochemical composition of pericardial effusions in patients undergoing pericardiocentesis.
Ben-Horin S; Bank I; Shinfeld A; Kachel E; Guetta V; Livneh A
Am J Cardiol; 2007 May; 99(9):1294-7. PubMed ID: 17478160
[TBL] [Abstract][Full Text] [Related]
13. Primary percutaneous balloon pericardiotomy for malignant pericardial effusion.
Swanson N; Mirza I; Wijesinghe N; Devlin G
Catheter Cardiovasc Interv; 2008 Mar; 71(4):504-7. PubMed ID: 18307242
[TBL] [Abstract][Full Text] [Related]
14. Cardiac tamponade in medical patients: a 10-year follow-up survey.
Cornily JC; Pennec PY; Castellant P; Bezon E; Le Gal G; Gilard M; Jobic Y; Boschat J; Blanc JJ
Cardiology; 2008; 111(3):197-201. PubMed ID: 18434725
[TBL] [Abstract][Full Text] [Related]
15. Malignant pericardial effusions: A retrospective look at etiology and prognosis in a tertiary oncological center.
Quirk T; Yao Y; Sverdlov A; Murch S
Asia Pac J Clin Oncol; 2023 Aug; 19(4):468-472. PubMed ID: 35950292
[TBL] [Abstract][Full Text] [Related]
16. [Women and pericardial neoplastic manifestations of the heart and pericardium].
Kisselbach C; Ristic AD; Pankuweit S; Karatolius K; Maisch B
Herz; 2005 Aug; 30(5):409-15; quiz 429-30. PubMed ID: 16132244
[TBL] [Abstract][Full Text] [Related]
17. [Intrapericardial infusion of etoposide and cisplatin in treating malignant pericardial effusion of non-small cell lung cancer].
Chen LK; Xu GC; Liang Y; Yang QY; Zhang LN
Ai Zheng; 2006 Apr; 25(4):505-8. PubMed ID: 16613690
[TBL] [Abstract][Full Text] [Related]
18. Evaluation and management of pericardial effusion in patients with neoplastic disease.
Maisch B; Ristic A; Pankuweit S
Prog Cardiovasc Dis; 2010; 53(2):157-63. PubMed ID: 20728703
[TBL] [Abstract][Full Text] [Related]
19. Management of tuberculous constrictive pericarditis and tuberculous pericardial effusion in Transkei: results at 10 years follow-up.
Strang JI; Nunn AJ; Johnson DA; Casbard A; Gibson DG; Girling DJ
QJM; 2004 Aug; 97(8):525-35. PubMed ID: 15256610
[TBL] [Abstract][Full Text] [Related]
20. Differential Impact of Constrictive Physiology after Pericardiocentesis in Malignancy Patients with Pericardial Effusion.
Cho IJ; Chang HJ; Chung H; Lee SE; Shim CY; Hong GR; Ha JW; Chung N
PLoS One; 2015; 10(12):e0145461. PubMed ID: 26691279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
